A brief review and clinical evidences of teriparatide therapy for atypical femoral fractures associated with long-term bisphosphonate treatment

A brief review and clinical evidences of teriparatide therapy for atypical femoral fractures associated with long-term bisphosphonate treatment

The risk of bisphosphonate (BP)-associated atypical femur fracture (AFF) has markedly increased over recent decades due to suppression of bone turnover, accumulation of structural micro-damage and reduction of bone remodeling consequent to long-term BP treatment. These medications further delay bone...

Full description

Bibliographic Details
Main Authors: Jianpeng Gao, Xiao Liu, Xiaoyong Wu, Xiaoya Li, Jianheng Liu, Ming Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Surgery
Subjects:
teriparatide
atypical femoral fractures
bisphosphonate
subtrochanteric fracture
therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2022.1063170/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2022.1063170/full

Similar Items